C反应蛋白可早期预测胃癌胃切除术后并发症
该研究纳入2014年连续334例胃癌胃切除术患者,术前及术后第1、4天检测炎症标志物,按Clavien-Dindo分级分为major与minor/no并发症组。
要点
- 术后第4天CRP是胃癌胃切除术后并发症最可靠的早期预测指标。
- 术后第4天CRP≥16.8 mg/dl为major并发症的显著预测因素。
- CRP预测准确性优于白细胞、中性粒细胞及血小板计数。
核心结论
- 术后第4天CRP是胃癌胃切除术后并发症最可靠的早期预测指标。
研究设计与样本
- 回顾性纳入2014年连续334例胃癌胃切除术患者,术前及术后第1、4天检测炎症标志物。
主要发现
- 术后第4天CRP预测major并发症的诊断准确性优于其他系统性炎症标志物。
- 多因素分析显示术后第4天CRP≥16.8 mg/dl是major并发症的显著预测因素。
关键数值与推荐
- major并发症定义为Clavien-Dindo分级>III级,minor/no并发症为I/II级或无并发症。
- 术后第4天CRP≥16.8 mg/dl为major并发症的显著预测因素。
临床怎么用
- 术后第4天检测CRP有助于早期识别胃癌胃切除术后major并发症高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical outcomes for postoperative complications (PCs) after gastrectomy depend on early diagnosis and intensive treatment. The aim of this study was to investigate the role of C-reactive protein (CRP) as an early predictor of PCs after gastrectomy for gastric cancer. METHODS: A total of 334 consecutive patients who underwent gastrectomy for gastric cancer in 2014 were enrolled in this study. Blood samples were obtained preoperatively, and at postoperative days 1 and 4 for the measurement of inflammatory markers (white blood cell, neutrophil, and platelet counts, and CRP). Patients were classified into groups of major and minor/no PCs, which were defined as patients with PCs of more than grade III and those with grade I/II or without PCs, respectively, according to the Clavien-Dindo classification. RESULTS: Twenty-five patients developed major PCs. The CRP on postoperative day 4 provided superior diagnostic accuracy in predicting major PCs compared to the other systematic inflammatory markers. Multivariate analysis identified a CRP level of 16.8 mg/dl or greater on postoperative day 4 as a significant predictive factor for major PCs. CONCLUSIONS: Among the various systemic inflammatory markers, CRP on postoperative day 4 is the most reliable predictor of PCs after gastrectomy for gastric cancer.
引用
- Kim EY, Yim HW, Park CH, et al. C-reactive protein can be an early predictor of postoperative complications after gastrectomy for gastric cancer. Surg Endosc. 2016. PMID: 27734201. doi:10.1007/s00464-016-5272-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。